Bicocca Open Archive

Logo unimib boa
COLLEDAN, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.066
AS - Asia 17.199
EU - Europa 12.409
SA - Sud America 2.888
Continente sconosciuto - Info sul continente non disponibili 1.477
AF - Africa 400
OC - Oceania 34
Totale 55.473
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.345
SG - Singapore 6.359
HK - Hong Kong 3.629
IT - Italia 3.435
RU - Federazione Russa 2.619
CA - Canada 2.480
VN - Vietnam 2.412
CN - Cina 2.269
BR - Brasile 2.216
IE - Irlanda 1.663
DE - Germania 1.109
SE - Svezia 1.053
FR - Francia 701
BD - Bangladesh 605
GB - Regno Unito 484
IN - India 382
UA - Ucraina 306
KR - Corea 299
AR - Argentina 276
FI - Finlandia 218
ID - Indonesia 191
IQ - Iraq 183
ES - Italia 171
NL - Olanda 153
TR - Turchia 147
ZA - Sudafrica 126
PK - Pakistan 110
EC - Ecuador 104
AT - Austria 94
SA - Arabia Saudita 90
MX - Messico 86
CO - Colombia 84
JP - Giappone 79
VE - Venezuela 69
BE - Belgio 65
CH - Svizzera 64
PH - Filippine 60
UZ - Uzbekistan 55
PL - Polonia 54
EG - Egitto 51
KE - Kenya 45
DK - Danimarca 43
PY - Paraguay 41
JM - Giamaica 40
MA - Marocco 40
MY - Malesia 40
CL - Cile 39
NP - Nepal 36
PE - Perù 33
JO - Giordania 30
DZ - Algeria 29
AE - Emirati Arabi Uniti 28
AU - Australia 28
CR - Costa Rica 27
PT - Portogallo 27
ET - Etiopia 26
TN - Tunisia 25
CZ - Repubblica Ceca 24
EU - Europa 23
AZ - Azerbaigian 22
RO - Romania 22
KZ - Kazakistan 21
LT - Lituania 18
PS - Palestinian Territory 18
UY - Uruguay 18
OM - Oman 16
HN - Honduras 15
DO - Repubblica Dominicana 14
IR - Iran 14
AL - Albania 13
NI - Nicaragua 13
RS - Serbia 13
IL - Israele 12
SN - Senegal 12
PA - Panama 11
TH - Thailandia 11
TT - Trinidad e Tobago 11
TW - Taiwan 11
LB - Libano 10
LY - Libia 9
BG - Bulgaria 8
BH - Bahrain 8
GR - Grecia 8
KW - Kuwait 8
BO - Bolivia 7
KG - Kirghizistan 7
SK - Slovacchia (Repubblica Slovacca) 7
XK - ???statistics.table.value.countryCode.XK??? 7
AO - Angola 6
CI - Costa d'Avorio 6
NZ - Nuova Zelanda 6
HU - Ungheria 5
LV - Lettonia 5
MU - Mauritius 5
QA - Qatar 5
SV - El Salvador 5
SY - Repubblica araba siriana 5
BY - Bielorussia 4
GE - Georgia 4
HR - Croazia 4
Totale 53.944
Salva come PNG Salva come JPEG
Città #
Hong Kong 3.582
Singapore 3.270
Toronto 2.288
Dublin 1.620
Ashburn 1.607
San Jose 1.334
Ann Arbor 1.253
Milan 889
New York 842
Princeton 820
Ho Chi Minh City 715
Fairfield 659
Santa Clara 650
Frankfurt am Main 634
Chicago 629
Chandler 586
Hanoi 575
The Dalles 545
Woodbridge 527
Dallas 515
Houston 439
Lawrence 385
Lauterbourg 378
Rome 378
Los Angeles 369
Wilmington 359
Altamura 339
Moscow 302
Seoul 278
Seattle 276
Beijing 259
Council Bluffs 237
Hefei 229
Cambridge 209
Jacksonville 195
São Paulo 177
Buffalo 172
San Diego 147
Helsinki 139
Shanghai 127
Andover 117
Dearborn 111
Da Nang 108
Jakarta 100
Haiphong 93
Nuremberg 90
London 87
Rio de Janeiro 84
Munich 79
Orem 79
Boardman 78
Boston 77
Baghdad 71
Turin 70
Columbus 68
Guangzhou 64
Salt Lake City 64
Nanjing 63
Figino 62
Atlanta 58
Hangzhou 57
Naples 57
Johannesburg 55
Tokyo 52
Belo Horizonte 48
Brooklyn 48
Florence 48
Biên Hòa 46
Brasília 46
Tashkent 46
Montreal 45
Denver 44
Hải Dương 44
Curitiba 43
San Francisco 43
Bologna 40
Vienna 40
Amsterdam 39
Brussels 39
Dhaka 39
Manchester 36
Nairobi 36
Norwalk 36
Phoenix 36
Riyadh 36
Lahore 35
Quito 35
Chennai 34
Tukwila 33
Campinas 32
Philadelphia 32
Changsha 31
Istanbul 31
Miami 31
Quận Bình Thạnh 31
Warsaw 31
Lachine 30
Porto Alegre 30
Thái Nguyên 30
Pune 29
Totale 32.131
Salva come PNG Salva come JPEG
Nome #
A multicentre outcome analysis to define global benchmarks for donation after circulatory death liver transplantation 764
Reply to: “Outcome of in situ split liver transplantation in Italy over the last 25 years: An alternative analysis and personal view” 506
Recipient hepatectomy technique may affect oncological outcomes of liver transplantation for hepatocellular carcinoma 501
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 466
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score 401
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 392
Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy 386
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study 376
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 368
Health related quality of life in chronic liver diseases 344
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 325
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 319
HCC persistence or recurrence after bridging therapy helps predict transplant list dropout and generate a more equitable exception policy 317
Multicentre evaluation of case volume in minimally invasive hepatectomy 304
Delaying surgery for patients with a previous SARS-CoV-2 infection 296
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 292
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 292
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis 291
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 285
Reno-portal bypass for non tumorous portal vein thrombosis in adult liver transplantation 280
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 275
Health Related Quality of Life in the Major Liver Conditions 274
COVID-19: role of resilience on the psychological impact of lockdown in liver transplant transitional candidates and recipients COVID-19: ruolo della resilienza sull’impatto psicologico del lockdown nei candidati e nei riceventi del trapianto di fegato (adolescenti-giovani adulti) 271
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 271
The impact of the COVID-19 outbreak on liver transplantation programs in Northern Italy 267
Vaccination Recommendations in Solid Organ Transplant Adult Candidates and Recipients 266
Technical and Clinical Outcomes of Laparoscopic–Laparotomic Hepatocellular Carcinoma Thermal Ablation with Microwave Technology: Case Series and Review of Literature 262
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 262
The Role of Imaging in Portal Vein Thrombosis: From the Diagnosis to the Interventional Radiological Management 255
Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling 253
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list 250
Treatment of hepatocellular carcinoma: A cost analysis of yttrium-90 transarterial radioembolization versus sorafenib 248
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 246
Balancing donor and recipient risk factors in liver transplantation: The value of D-MELD with particular reference to HCV recipients 243
Combined double lung-liver transplantation for cystic fibrosis without cardio-pulmonary by-pass. 242
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients 241
Preliminary Analysis of the Impact of COVID-19 Outbreak on Italian Liver Transplant Programs 241
Biliary complications in pediatric liver transplantation: findings of percutaneous transhepatic cholangiography in a large single-center cohort 241
Post-operative heparin reduces early venous thrombotic complications after orthotopic paediatric liver transplantation 239
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 238
Arterioportal fistulas (Apfs) in pediatric patients: Single center experience with interventional radiological versus conservative management and clinical outcomes 236
Covid-19 and gender: lower rate but same mortality of severe disease in women-an observational study 233
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in ovarian and gastrointestinal peritoneal carcinomatosis: Results from a 7-year experience 232
Portal vein thrombosis and liver transplantation: management, matching, and outcomes: a retrospective multicenter cohort study 228
Extended right split liver graft for primary transplantation in children and adults. 227
Nuclear expression of s100a4 calcium binding protein increases cholangiocarcinoma invasiveness and metastasization 226
Is minimally invasive liver surgery a reasonable option in recurrent HCC? A snapshot from the I Go MILS registry 225
Selective use of ex-situ machine perfusion after normothermic regional perfusion in liver transplantation from donation after circulatory death 225
Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria 224
Current Endovascular Management of Arterial Complications After Pediatric Liver Transplantation in a Tertiary Center 224
Liver transplant in cystic fibrosis: a poll among European centers. A study from the European Liver Transplant Registry 222
Laparoscopic liver resection of hepatocellular carcinoma located in unfavorable segments: a propensity score-matched analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 222
Early detection of the graft failure after pediatric liver transplantation: a Bergamo experience 221
Treatment with pegylated interferon and ribavirin for hepatitis C virus-associated severe cryoglobulinemia in a liver/kidney transplant recipient 218
Trapianto intestinale 216
Venous outflow obstruction in pediatric left lateral segment split liver transplantation 214
Living Donor Lung Transplantation After Hematopoietic Stem Cell Transplantation From the Same Donor: A Risk Worth Taking 206
Successful pre- and posttransplant sofosbuvir-based anti-hepatitis C virus treatment in persons living with human immunodeficiency virus infection 205
Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma 204
Use of extended right grafts from in situ split livers in adult liver transplantation: a comparison with whole-liver transplants. 200
Full-right-full-left split liver transplantation: The retrospective analysis of an early multicenter experience including graft sharing 199
AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool 198
Extended criteria liver donation after circulatory death with prolonged warm ischemia: a pilot experience of normothermic regional perfusion and no subsequent ex-situ machine perfusion 198
Experience with the use of basiliximab in liver transplantation--use in pediatric and adult recipients in combination with cyclosporine or tacrolimus 195
Exploring auxiliary liver transplantation in the era of transplant oncology - A proposal for a new liver splitting program (ALERT-50) 193
A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the Liver Match study 192
Successful Lung Transplantation From a Donor With Previous Severe COVID-19 Pneumonia 189
Improving Outcome of Selected Patients With Non-Resectable Hepatic Metastases From Colorectal Cancer With Liver Transplantation: A Prospective Parallel Trial (COLT trial) 186
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 186
Physiological reno-portal bypass in liver transplantation with non-tumorous portal vein thrombosis 184
Improving outcomes of in situ split liver transplantation in Italy over the last 25 years 184
Very Early Introduction of Everolimus in De Novo Liver Transplantation: Results of a Multicenter, Prospective, Randomized Trial 183
R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation 183
Liver transplants in children: The 8 years experience in Bergamo 183
A prospective policy development to increase split-liver transplantation for 2 adult recipients: Results of a 12-year multicenter collaborative study 180
Correction to: Diffusion, outcomes and implementation of minimally invasive liver surgery: a snapshot from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry (Updates in Surgery, (2017), 69, 3, (271-283), 10.1007/s13304-017-0489-x) 178
Early post-liver transplant surgical morbidity in HIV-infected recipients: risk factor for overall survival? A nationwide retrospective study 177
A national mandatory-split liver policy: A report from the Italian experience 177
Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial 171
Liver transplantation for hepatocellular carcinoma: Bergamo experience 171
A matched pair analysis of multicenter longterm follow-up after split-liver transplantation with extended right grafts 170
Location and allocation: inequity of access to liver transplantation for patients with severe acute‐on‐chronic liver failure in Europe 170
Safety and Efficacy of Subcutaneous Hepatitis B Immunoprophylaxis using" on demand" Approach: A Single Center Experience 169
Safety and Efficacy of Subcutaneous Hepatitis B Immunoprophylaxis using “on demand” Approach: A Single Center Experience 167
Fifteen years and 382 extended right grafts from in situ split livers in a multicenter study: Are these still extended criteria liver grafts? 165
Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic 164
Transitional care in pediatric liver transplantation: do we need to structure a personalized program? 163
Evidence for biliary epithelial to mesenchymal transition in human cholangiocarcinoma 163
Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study 162
Favorable outcome of primary liver transplantation in children with cirrhosis and hepatocellular carcinoma 159
Evolution of minimally invasive techniques and surgical outcomes of ALPPS in Italy: a comprehensive trend analysis over 10 years from a national prospective registry 158
Indications and successes of intestinal transplantation in children in the 21st century: A retrospective cohort study 157
EVIDENCE FOR EPITHELIAL-MESENCHYMAL TRANSITION IN HUMAN CHOLANGIOCARCINOMA 156
Identifying the Aetiology of Acute Liver Failure Is Crucial to Impact Positively on Outcome 155
Patterns of hepatitis delta virus reinfection and disease in liver transplantation 153
D-MELD, a Powerful Instrument To Optimize Donor-2-Recipient Match. Differences between US and Italy 153
Liver Perfusion in Multiorgan Harvesting for Transplantation 152
Prolonged and repeated courses of OKT3 after liver transplantation 151
Pre-transplant alpha-fetoprotein > 25.5 and its dynamic on waitlist are predictors of HCC recurrence after liver transplantation for patients meeting milan criteria 151
B-Hepatitis and Liver-Transplantation 149
Totale 23.892
Salva come PNG Salva come JPEG
Categoria #
all - tutte 243.675
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 243.675
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.468 0 81 172 585 183 192 63 206 90 969 155 772
2022/20234.576 815 1.320 379 209 212 860 54 183 248 84 148 64
2023/20244.548 76 98 164 160 682 1.142 894 139 549 66 78 500
2024/202511.943 647 1.854 488 490 1.059 272 500 338 1.693 1.843 923 1.836
2025/202625.120 2.585 1.831 1.771 2.120 1.973 1.183 3.220 1.223 1.760 1.818 3.244 2.392
2026/20271.342 936 406 0 0 0 0 0 0 0 0 0 0
Totale 55.473